Optimal Timing for Anti-Hyperuricemic Agents

Practical Administration Guidelines

The American College of Rheumatology recommends no specific time of day for administering xanthine oxidase inhibitors like allopurinol or febuxostat, focusing on consistent daily administration instead 1, 2
The American College of Rheumatology suggests starting allopurinol at low doses (≤100 mg/day, or ≤50 mg/day in CKD stage ≥3) with dose titration every 2-5 weeks to achieve serum urate <6 mg/dL, regardless of administration time 1, 2
The maximum allopurinol dose is 800 mg/day, which can be given as a single daily dose without regard to timing, according to the American College of Rheumatology 1

Concomitant anti-inflammatory prophylaxis is mandatory when initiating urate-lowering therapy, with colchicine 0.5-1 mg/day for 3-6 months, as recommended by the American College of Rheumatology 1, 4
Starting urate-lowering therapy during an acute flare is conditionally recommended, rather than waiting for flare resolution, as this does not prolong flare duration and prevents delayed therapy, although the strength of evidence is not specified 3

The American College of Rheumatology guidelines imply that delayed initiation of urate-lowering therapy leads to progressive joint damage, highlighting the importance of consistency over specific timing 4